Bombay High Court today stayed the order of the Maharashtra Food & Drug Administration (Maharashtra FDA) suspending the license of Johnson & Johnson to manufacture cosmetic products at its Mulund plant. The bench ordered Maharashtra FDA to hear the matter afresh. However, while declining to quash FDA’s order, Justice S J Vazifdar and Justice M S Sonak left it open for whistleblower Dr Ajit Telang to intervene in the matter before FDA, or approach high court with a PIL. “Johnson is manufacturing the cosmetic products on a loaned licence,” Justice Vazifdar explained to Dr Telang’s advocate. “If manufacturing is not allowed to resume, the suffering of the other party i.e. the licence owner, will be needlessly prolonged,” he said. Dr Ajit Telang, who had worked for 14 years at Johnson’s Mulund plant, complained to Johnson’s headquarters in 2008 regarding the contamination of the 1.6 lakh containers of Baby Powder with carcinogenic Ethylene Oxide. Later, in 2011, he alerted FDA and pursued the matter doggedly until the permission to manufacture cosmetic products at its Mulund plant was finally suspended in June 2013.
Posted on: Thu, 19 Sep 2013 18:16:00 +0000
Trending Topics
Recently Viewed Topics
© 2015